magnifying glass
logo for Intercept Pharmaceuticals

Intercept Pharmaceuticals

Manufacturing · New York, United States · 500 Employees

Get Full Access

Who is Intercept Pharmaceuticals

Intercept is a biotech firm focused on the development of products to treat liver diseases. Intercept was founded in 2002 and is headquartered in New York, NY.Read More

Headquarters

Headquarters:

10 Hudson Yards, Fl 37, New York City, New York, 10001, United States
Phone Number

Phone Number:

(646) 747-1000
Revenue

Revenue:

$354 Million
Stock Symbol

Stock Symbol:

ICPT
Intercept Pharmaceuticals's Social Media
SIC Code 28,283
NAICS Code 325414,32541
Ticker NASDAQ: ICPT
Popular Searches:

intercept pharmaceuticals inc

Intercept Pharmaceuticals, Inc.

Intercept Pharmaceuticals , Inc.

Intercept Pharmaceuticals

Intercept Pharmaceuticals Inc.

Top Competitors of Intercept Pharmaceuticals

Employess
250
revenue
$14 Million

1

Employess
393
revenue
$132 Million

2

Employess
393
revenue
$18 Million

3

Employess
350
revenue
$8 Million

4

Employess
313
revenue
$16 Million

5

Employess
304
revenue
$15 Million

6

Intercept Pharmaceuticals's Org Chart

Alex Martin
Alex Martin

Chief Executive Officer

PhonePhoneEmailEmail
David Ford
David Ford

Chief Human Resources Officer

PhonePhoneEmailEmail
Andrew Saik
Andrew Saik

Chief Financial Officer

PhonePhoneEmailEmail

PhonePhoneEmailEmail
Illustration of an envelope

Intercept Pharmaceuticals Company Metrics

Company Insights
Employee Growth Rate
Funding
Funding DateRoundAmountInvestors

May 10, 2019

Stock Issuance/Offering

$200M

-

May 10, 2019

Debt

$210M

-

Apr 05, 2018

Stock Issuance/Offering

$250M

Samsara BioCapital, L.P.

See More

$1B

Total Funding Amount

$200M

Most Recent Funding Amount

11

Number of Funding Rounds

Revenue
QuarterRevenue

'21 - Q1

261080000

'21 - Q2

261080000

Acquisitions & Subsidiaries

Dec 14, 2018

ADVANZ PHARMA

Oct 31, 2017

Abcur

Nov 25, 2014

Correvio

Mar 30, 2014

Paralex

Nov 21, 2009

Pinnacle Biologics

Artesian Therapeutics

See More Acquisitions & Subsidiaries

Intercept Pharmaceuticals's Tech Stack

Microsoft Azure

By

Microsoft

Achievers

By

Achievers

ASP.NET

By

Microsoft

SonicWALL

By

Dell
See more technologies

Intercept Pharmaceuticals News & Media

Intercept Pharmaceuticals Reports Second Quarter 2022 Financial Results and Provides Business Update

Worldwide Ocaliva® non-GAAP adjusted net sales in PBC of $100.4 million; U.S. net sales of $71.8 million representing 5% growth over the prior year quarter

Intercept Announces PBC Data Presentations at The International Liver Congress™ 2022

MORRISTOWN, N.J., June 21, 2022 (GLOBE NEWSWIRE) -- Intercept Pharmaceuticals, Inc. (Nasdaq:ICPT), a biopharmaceutical company focused on the development and commercialization of novel therapeutics to treat progressive non-viral liver diseases, today announced that multiple abstracts highlighting the benefits of obeticholic acid (OCA) in individuals with primary biliary cholangitis (PBC) will be presented at the International Liver Congress™ 2022, the 57th Annual Meeting of the European Associat

Intercept Provides Update on NASH Regulatory Timeline

MORRISTOWN, N.J., June 06, 2022 (GLOBE NEWSWIRE) -- Intercept Pharmaceuticals, Inc. (Nasdaq:ICPT), a biopharmaceutical company focused on the development and commercialization of novel therapeutics to treat non-viral liver diseases, today announced an update on the timing of its pre-submission meeting with the U.S. Food and Drug Administration (FDA) regarding the potential resubmission of its nonalcoholic steatohepatitis (NASH) New Drug Application (NDA) based on an interim analysis of the REGEN
Subscribe to "Intercept Pharmaceuticals" News

Frequently Asked Questions regarding Intercept Pharmaceuticals

Where are Intercept Pharmaceuticals’s headquarters?

Intercept Pharmaceuticals’s headquarters are in 10 Hudson Yards, Fl 37, New York City, New York, 10001, United States

What is Intercept Pharmaceuticals’s phone number?

Intercept Pharmaceuticals’s phone number is (646) 747-1000

What is Intercept Pharmaceuticals’s stock symbol?

Intercept Pharmaceuticals’s stock symbol is ICPT

What is Intercept Pharmaceuticals’s official website?

Intercept Pharmaceuticals’s official website is www.interceptpharma.com

What is Intercept Pharmaceuticals’s Revenue?

Intercept Pharmaceuticals’s revenue is $354 Million

What is Intercept Pharmaceuticals’s SIC code?

Intercept Pharmaceuticals’s SIC: 28,283

What is Intercept Pharmaceuticals’s NAICS code?

Intercept Pharmaceuticals’s NAICS: 325414,32541

How many employees are working in Intercept Pharmaceuticals?

Intercept Pharmaceuticals has 500 employees

What is Intercept Pharmaceuticals’s industry?

Intercept Pharmaceuticals is in the industry of: Manufacturing, Pharmaceuticals, Chemicals & Related Products

Who are Intercept Pharmaceuticals’s main competitors?

Intercept Pharmaceuticals's main competitors are: Acceleron Pharma, Atara Bio, Relypsa, GBT

What companies has Intercept Pharmaceuticals acquired?

Intercept Pharmaceuticals has acquired the companies: ADVANZ PHARMA, Abcur, Correvio, Paralex

What is Intercept Pharmaceuticals's tech stack?

The technologies that are used by Intercept Pharmaceuticals are: Microsoft Azure, Achievers, ASP.NET, SonicWALL

Who is Intercept Pharmaceuticals's CEO?

Intercept Pharmaceuticals's CEO is Jerome Durso

Who is Intercept Pharmaceuticals's CFO?

Intercept Pharmaceuticals's CFO is Andrew Saik

See more information about Intercept Pharmaceuticals
4.4/5 on G2 Crowd